The Partner trial is a randomized, controlled, multi-center study that assigns patients into one of two arms: a ‘non-surgical’ arm, in which the Edwards’s Sapien valve is compared
Mr Wallwork will also be chairing the company’s scientific advisory board where his knowledge and background in pulmonary hypertension as well as his experience in the management of
The alliance provides clinical trial sponsors direct access to the world’s most experienced team of thorough QT scientists, unparalleled subject enrollment and bed capacity, integrated study management and
In conjunction with this financing, Anders Hove of Venrock Associates and Myles Greenberg of CHL Medical Partners will join Still River Systems’s board of directors. Still River Systems
The ImCardia is an elastic device placed on the outer surface of the left ventricle. A breakthrough preclinical study has shown the ImCardia to harness elastic energy produced
Year-to-date, nine-month revenues rose 17% in the current fiscal year to $87,831,000 from FY 2008’s $75,299,000. Year-to-date net income for the first nine months of Neogen’s 2009 fiscal
“We are delighted about Linda’s decision to join Arbor Vita at this time,” commented Peter S. Lu, founder, president and chief executive officer. “Linda brings to AVC an
Roche has signed a definitive agreement with innovatis, a provider of automated cell analysis solutions, pursuant to which, Roche will acquire 100% of innovatis for E15m. This acquisition
Lanxess reported a net loss of €41m for the fourth quarter of 2008, in comparison with a net profit of €5m in the year-ago period of 2007. Sales
Forma Therapeutics, a biopharmaceutical company, and the Experimental Therapeutics Centre of Singapore, have signed a collaboration agreement to leverage Forma’s transformative chemistry platform to discover novel compounds for
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.